Guardant Health
GH
$29.64
Share price
-1.40%
Change (1 day)
-43.09%
Change (1 year)
Categories
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.
Guardant Health (GH) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $1.54 B
According to Guardant Health 's latest financial reports the company's total liabilities are $1.54 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Guardant Health - Total liabilities on balance sheet (from 2017 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $1.54 B | -0.62% |
| 2021-12-31 | $1.55 B | 70.22% |
| 2020-12-31 | $0.91 B | 699.87% |
| 2019-12-31 | $0.11 B | 83.41% |
| 2018-12-31 | $62.45 M | 81.9% |
| 2017-12-31 | $34.33 M | -6.88% |
| 2016-12-31 | $36.86 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Neogen NEOG | $1.42 B | -8.21% | 🇺🇸 USA |
 Natera NTRA | $0.65 B | -57.88% | 🇺🇸 USA |